Toxic acute hepatitis and hepatic fibrosis after consumption of chaparral tablets

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 11, 2004, Pages 1168-1171

  Kauma, Heikki ^a   Koskela, R ^b   Makisalo H ^b   Autio Harmainen, H ^b   Lehtola, J ^b   Hockerstedt K ^b  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Hepatic fibrosis; Herbal medication; Toxic hepatitis

Indexed keywords

CHAPARRAL; HERBACEOUS AGENT; NORDIHYDROGUAIARETIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; FEMALE; HERBAL MEDICINE; HUMAN; JAUNDICE; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TOXICITY; PRIORITY JOURNAL; TABLET; TOXIC HEPATITIS; TRADITIONAL MEDICINE;

ADULT; FEMALE; HEPATITIS, TOXIC; HUMANS; LARREA; LIVER; LIVER CIRRHOSIS; PHYTOTHERAPY; PLANT PREPARATIONS;

EID: 8844287594     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410007926     Document Type: Article

References (17)

1. Cupp MJ editor. Toxicology and clinical pharmacology of herbal products. New Jersey: Humana Press; 2000. p. 177-90.
2. Centers for Disease Control and Prevention. Chaparral-induced toxic hepatitis - California and Texas, 1992. MMWR Morb Mortal Wkly Rep 1992;41:812-4.
3. Sheikh NM, Philen RM, Love LA. Chaparral-associated hepatotoxity. Arch Intern Med 1997;157:913-9.
4. Tierra M. The way of herbs. New York: Simon and Schuster; 1990. p. 139-40.
5. Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755 C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med 1984;13:53-60.
6. Evan AP, Gardner KD, Jr. Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int 1979;15:7.
7. Smith AY, Feddersen RM, Gardner KD, Jr, Davis CJ. Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. J Urol 1994:152:2089-91.
8. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990;12:203-6.
9. Smith BC, Desmond PV. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust NZJ Med 1993;23:526.
10. Alderman S, Kailas S, Goldfarb S, Singaram C, Malone DG. Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. J Clin Gastroenterol 1994;19:242-7.
11. Batchelor WB, Heathcote J, Wanless IR. Chaparral-induced hepatic injury. Am J Gastroenterol 1995;90:831-3.
12. Gordon DF, Rosenthal G, Hart J, Sirota R, Baker AL. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 1995;273:489-90.
13. Estes JD, Stolpman D, Olyaei A, Corless CL, Ham JM, Schwartz JM, Orloff SL. High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003;138:852-8.
14. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997;26 Suppl 1:47-51.
15. Stickel F, Egerer G, Seitz HK. Hepatotoxicity of botanicals. Public Health Nutr 2000;3:113-24.
16. Agarwal R, Wang ZY, Bik DP, Mukhtar H. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos 1991;19:620-4.
17. Obermeyer WR, Musser SM, Betz JM, Casey RE, Pohland AE, Page SW. Chemical studies of phytoestrogens in flax and chaparral (43824). Proc Exp Biol Med 1995;208:6-12.